INFINITT Healthcare Co., Ltd. (KOSDAQ:071200)
South Korea · Delayed Price · Currency is KRW 6,000.00
-250.00 (-4.00%)
At close: Apr 2, 2026
INFINITT Healthcare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 102,392 | 95,750 | 85,860 | 88,286 | 78,170 |
Other Revenue | - | - | - | - | -0 |
| 102,392 | 95,750 | 85,860 | 88,286 | 78,170 | |
Revenue Growth (YoY) | 6.94% | 11.52% | -2.75% | 12.94% | 11.56% |
Cost of Revenue | 40,335 | 37,945 | 36,691 | 34,754 | 32,371 |
Gross Profit | 62,057 | 57,805 | 49,169 | 53,532 | 45,799 |
Selling, General & Admin | 35,478 | 37,969 | 34,086 | 33,565 | 27,952 |
Research & Development | 7,745 | 9,208 | 8,635 | 8,039 | 7,378 |
Amortization of Goodwill & Intangibles | 124.44 | 134.47 | 133.61 | 138.67 | 108.5 |
Other Operating Expenses | 355.52 | 277.76 | 254.94 | 268.2 | 272.09 |
Operating Expenses | 47,840 | 50,281 | 45,226 | 45,675 | 38,691 |
Operating Income | 14,217 | 7,524 | 3,942 | 7,857 | 7,108 |
Interest Expense | -106.84 | -131.75 | -132.38 | -121.79 | -118.18 |
Interest & Investment Income | 3,267 | 3,004 | 1,779 | 1,164 | 743.52 |
Earnings From Equity Investments | 21.43 | -38.63 | 100.77 | 22.47 | 65.12 |
Currency Exchange Gain (Loss) | -514.66 | 3,627 | 675.15 | -698.68 | 1,836 |
Other Non Operating Income (Expenses) | 462.87 | 85.79 | -12.43 | 320.9 | 2,311 |
EBT Excluding Unusual Items | 17,346 | 14,070 | 6,353 | 8,544 | 11,946 |
Gain (Loss) on Sale of Investments | 17,981 | 34,039 | 15,210 | -11,648 | 14,071 |
Gain (Loss) on Sale of Assets | 13.93 | -30.97 | -5.79 | 0.46 | -1.11 |
Asset Writedown | - | -0.08 | - | - | - |
Other Unusual Items | - | - | 20.38 | 8.84 | 8.98 |
Pretax Income | 35,341 | 48,079 | 21,578 | -3,095 | 26,025 |
Income Tax Expense | 8,588 | 7,516 | 3,972 | -3,256 | 3,386 |
Earnings From Continuing Operations | 26,753 | 40,562 | 17,606 | 160.93 | 22,639 |
Earnings From Discontinued Operations | - | -2,066 | -818.3 | - | - |
Net Income to Company | 26,753 | 38,497 | 16,788 | 160.93 | 22,639 |
Minority Interest in Earnings | -348.5 | -698.78 | -326.95 | -29.36 | 17.65 |
Net Income | 26,405 | 37,798 | 16,461 | 131.57 | 22,656 |
Net Income to Common | 26,405 | 37,798 | 16,461 | 131.57 | 22,656 |
Net Income Growth | -30.14% | 129.63% | 12411.29% | -99.42% | 239.02% |
Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 24 |
Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 24 |
Shares Change (YoY) | -0.02% | 0.04% | - | -0.19% | 0.19% |
EPS (Basic) | 1083.00 | 1550.00 | 675.27 | 5.40 | 929.44 |
EPS (Diluted) | 1083.00 | 1550.00 | 675.27 | 5.00 | 928.00 |
EPS Growth | -30.13% | 129.54% | 13405.31% | -99.46% | 238.69% |
Free Cash Flow | 13,273 | 11,483 | 9,556 | 8,281 | 15,424 |
Free Cash Flow Per Share | 544.40 | 470.89 | 392.03 | 339.72 | 631.52 |
Gross Margin | 60.61% | 60.37% | 57.27% | 60.63% | 58.59% |
Operating Margin | 13.88% | 7.86% | 4.59% | 8.90% | 9.09% |
Profit Margin | 25.79% | 39.48% | 19.17% | 0.15% | 28.98% |
Free Cash Flow Margin | 12.96% | 11.99% | 11.13% | 9.38% | 19.73% |
EBITDA | 16,552 | 10,118 | 6,441 | 10,418 | 9,468 |
EBITDA Margin | 16.17% | 10.57% | 7.50% | 11.80% | 12.11% |
D&A For EBITDA | 2,335 | 2,594 | 2,498 | 2,561 | 2,360 |
EBIT | 14,217 | 7,524 | 3,942 | 7,857 | 7,108 |
EBIT Margin | 13.88% | 7.86% | 4.59% | 8.90% | 9.09% |
Effective Tax Rate | 24.30% | 15.63% | 18.41% | - | 13.01% |
Advertising Expenses | 2,091 | 2,099 | 1,999 | 1,695 | 804.23 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.